Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Nymox Pharmaceutical Corp (NYMX) Common Stock USD NPV

Sell:$1.65 Buy:$1.67 Change: $0.02 (1.18%)
NASDAQ:1.67%
Market closed |  Prices as at close on 16 August 2019 | Switch to live prices |
Sell:$1.65
Buy:$1.67
Change: $0.02 (1.18%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed |  Prices as at close on 16 August 2019 | Switch to live prices |
Sell:$1.65
Buy:$1.67
Change: $0.02 (1.18%)
Market closed |  Prices as at close on 16 August 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also owns rights for its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.

Contact details

Address:
9900 Cavendish Blvd Suite 306
SAINT-LAURENT
H4M 2V2
Canada
Telephone:
+ ()
Website:
www.nymox.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NYMX
ISIN:
BSP733981026
Market cap:
$115.12 million
Shares in issue:
67.93 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
Bahamas
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.